Table 2.
Top 10 representative pathways according to gene count.
| Pathway ID | Pathway | Corrected P value | Gene count | Annotated genes |
|---|---|---|---|---|
| KEGG:hsa04151 | PI3K-Akt signaling pathway | 2.34E-13 | 9 | AKT1, CDK2, CDK6, EGFR, GSK3B, IGF1R, KDR, MET, PTK2 |
| KEGG:hsa05200 | Pathways in cancer | 8.86E-13 | 9 | AKT1, CDK2, CDK6, DAPK1, EGFR, GSK3B, IGF1R, MET, PTK2 |
| KEGG:hsa04510 | Focal adhesion | 5.02E-13 | 8 | AKT1, EGFR, GSK3B, IGF1R, KDR, MET, PTK2, SRC |
| KEGG:hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.51E-13 | 7 | AKT1, EGFR, GSK3B, IGF1R, KDR, MET, SRC |
| KEGG:hsa05205 | Proteoglycans in cancer | 1.30E-10 | 7 | AKT1, EGFR, IGF1R, KDR, MET, PTK2, SRC |
| KEGG:hsa04015 | Rap1 signaling pathway | 2.71E-08 | 6 | AKT1, EGFR, IGF1R, KDR, MET, SRC |
| KEGG:hsa04012 | ErbB signaling pathway | 3.76E-08 | 5 | AKT1, EGFR, GSK3B, PTK2, SRC |
| KEGG:hsa04068 | FoxO signaling pathway | 3.31E-07 | 5 | AKT1, CDK2, EGFR, IGF1R, PLK1 |
| KEGG:hsa04014 | Ras signaling pathway | 5.04E-06 | 5 | AKT1, EGFR, IGF1R, KDR, MET |
| KEGG:hsa04144 | Endocytosis | 9.94E-06 | 5 | EGFR, IGF1R, KDR, MET, SRC |